Axel F. Wenzel
Axel F. Wenzel, PhD; MSc; BSc; FTOPRA, is CEO of p.ss.t Pharma Scientific Services Team and Chief Scientific officer (CSO) and Director of EU Vigilance Ltd. He earned a PhD in life sciences and a Masters degree (Dipl. Biol.) in Medical Microbiology at the Universities of Saarbrücken (Germany) and Innsbruck (Austria).
Axel has expertise in a range of disciplines including: basic and clinical microbiology, pharmacology and toxicology, pharmaceutical R&D, project management in drug development, drug regulatory affairs and pharmacovigilance. After 10 years in various management positions at a research Institute he served for 7+ years at the German subsidiary as a liaison officer between headquarters in the US and the German/European affiliates concerning new development drugs as well as Head of New Product Regulatory Affairs.
Axel served as a board member of TOPRA for 3 years and was co-founder and editor in chief of the leading regulatory affairs journal Regulatory Rapporteur. He is also President of PEFRAS (Pan European Federation of Regulatory Affairs Societies), MEGRA (Mid European Society for Regulatory Affairs Professionals) and Vice President of the EAPB (European Association of Pharmaceutical Biotechnology).
Axel has trained professionals from various organisations as well as lecturing as a professor at the University of Essen for Drug Regulatory Affairs. He has also published more than 80 scientific articles, columns and co-authored books.
PTI is part of the Knowledge & Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.